Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page:

LDLR gene

low density lipoprotein receptor

Normal Function

The LDLR gene provides instructions for making a protein called the low-density lipoprotein receptor. This receptor binds to particles called low-density lipoproteins (LDLs), which are the primary carriers of cholesterol in the blood. Cholesterol is a waxy, fat-like substance that is produced in the body and obtained from foods that come from animals.

Low-density lipoprotein receptors sit on the outer surface of many types of cells, where they pick up LDLs circulating in the bloodstream and transport them into the cell. Once inside the cell, the LDL is broken down to release cholesterol. The cholesterol is then used by the cell, stored, or removed from the body. After low-density lipoprotein receptors drop off their cargo, they are recycled back to the cell surface to pick up more LDLs.

Low-density lipoprotein receptors play a critical role in regulating the amount of cholesterol in the blood. They are particularly abundant in the liver, which is the organ responsible for removing most excess cholesterol from the body. The number of low-density lipoprotein receptors on the surface of liver cells determines how quickly cholesterol is removed from the bloodstream.

Health Conditions Related to Genetic Changes

Familial hypercholesterolemia

Mutations in the LDLR gene cause a form of high cholesterol called familial hypercholesterolemia. More than 2,000 mutations have been identified in this gene. Some of these genetic changes reduce the number of low-density lipoprotein receptors produced within cells. Other mutations disrupt the receptor's ability to remove LDLs from the blood. As a result, people with mutations in the LDLR gene have very high blood cholesterol levels. As the excess cholesterol circulates through the bloodstream, it is deposited abnormally in tissues such as the skin, tendons, and arteries that supply blood to the heart (coronary arteries). A buildup of cholesterol in the walls of coronary arteries greatly increases a person's risk of having a heart attack.

Most people with familial hypercholesterolemia inherit one altered copy of the LDLR gene from an affected parent and one normal copy of the gene from the other parent. These cases are associated with an increased risk of early heart disease, typically beginning in a person's forties or fifties. Rarely, a person with familial hypercholesterolemia is born with two mutated copies of the LDLR gene. This situation occurs when the person has two affected parents, each of whom passes on one altered copy of the gene. The presence of two LDLR gene mutations results in a more severe form of hypercholesterolemia that usually appears in childhood.

More About This Health Condition

Other Names for This Gene

  • FHC
  • LDL receptor
  • LDLCQ2
  • Low density lipoprotein (LDL) receptor
  • low density lipoprotein receptor (familial hypercholesterolemia)

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Gene and Variant Databases


  • Defesche JC. Low-density lipoprotein receptor--its structure, function, and mutations. Semin Vasc Med. 2004 Feb;4(1):5-11. doi: 10.1055/s-2004-822993. Citation on PubMed
  • Goldstein JL, Brown MS. Molecular medicine. The cholesterol quartet. Science. 2001 May 18;292(5520):1310-2. doi: 10.1126/science.1061815. No abstract available. Citation on PubMed
  • Jeon H, Blacklow SC. Structure and physiologic function of the low-density lipoprotein receptor. Annu Rev Biochem. 2005;74:535-62. doi: 10.1146/annurev.biochem.74.082803.133354. Citation on PubMed
  • Kong WJ, Liu J, Jiang JD. Human low-density lipoprotein receptor gene and its regulation. J Mol Med (Berl). 2006 Jan;84(1):29-36. doi: 10.1007/s00109-005-0717-6. Epub 2005 Nov 16. Citation on PubMed
  • Marais AD, Firth JC, Blom DJ. Homozygous familial hypercholesterolemia and its management. Semin Vasc Med. 2004 Feb;4(1):43-50. doi: 10.1055/s-2004-822985. Citation on PubMed
  • Ueda M. Familial hypercholesterolemia. Mol Genet Metab. 2005 Dec;86(4):423-6. doi: 10.1016/j.ymgme.2005.11.003. No abstract available. Citation on PubMed
  • van Aalst-Cohen ES, Jansen AC, de Jongh S, de Sauvage Nolting PR, Kastelein JJ. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia. Semin Vasc Med. 2004 Feb;4(1):31-41. doi: 10.1055/s-2004-822984. Citation on PubMed

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.